NYSE:BAX - Baxter International Stock Price, News, & Analysis

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

Baxter International declared a quarterly dividend on Tuesday, November 13th. Stockholders of record on Monday, December 3rd will be given a dividend of $0.19 per share on Wednesday, January 2nd. This represents a $0.76 dividend on an annualized basis and a dividend yield of 1.18%. The ex-dividend date of this dividend is Friday, November 30th. View Baxter International's Dividend History.

Baxter International declared that its Board of Directors has approved a share buyback plan on Tuesday, November 13th 2018, which allows the company to repurchase $2,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization allows the company to buy up to 6.1% of its stock through open market purchases. Stock repurchase plans are generally an indication that the company's board believes its shares are undervalued.

Baxter International Inc (NYSE:BAX) announced its quarterly earnings data on Wednesday, October, 31st. The medical instruments supplier reported $0.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.74 by $0.06. The medical instruments supplier had revenue of $2.77 billion for the quarter, compared to analyst estimates of $2.79 billion. Baxter International had a return on equity of 17.67% and a net margin of 10.90%. The business's revenue for the quarter was up 2.2% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.64 earnings per share. View Baxter International's Earnings History.

Baxter International is scheduled to release their next quarterly earnings announcement on Thursday, February 7th 2019. View Earnings Estimates for Baxter International.

Baxter International updated its fourth quarter earnings guidance on Wednesday, October, 31st. The company provided EPS guidance of $0.71-0.73 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.77. Baxter International also updated its FY 2018 guidance to $2.98-3.00 EPS.

15 brokers have issued 12-month price targets for Baxter International's stock. Their predictions range from $66.00 to $85.00. On average, they anticipate Baxter International's stock price to reach $74.00 in the next twelve months. This suggests a possible upside of 14.9% from the stock's current price. View Analyst Price Targets for Baxter International.

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last year. There are currently 2 sell ratings, 3 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Baxter International.

Press coverage about BAX stock has trended somewhat negative recently, InfoTrie Sentiment reports. InfoTrie rates the sentiment of media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Baxter International earned a coverage optimism score of -1.9 on InfoTrie's scale. They also assigned news headlines about the medical instruments supplier a news buzz of 9.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the stock's share price in the near future.

Some companies that are related to Baxter International include 3M (MMM), Becton Dickinson and (BDX), Stryker (SYK), Boston Scientific (BSX), FRESENIUS SE &/S (FSNUY), ResMed (RMD), ABIOMED (ABMD), DexCom (DXCM), Teleflex (TFX), Hill-Rom (HRC), Haemonetics (HAE), Globus Medical (GMED), ICU Medical (ICUI), Insulet (PODD) and Penumbra (PEN).

Baxter International's stock is owned by many different of institutional and retail investors. Top institutional investors include BlackRock Inc. (7.41%), FMR LLC (5.52%), AQR Capital Management LLC (1.26%), Standard Life Aberdeen plc (1.08%), Veritas Asset Management LLP (0.89%) and Janus Henderson Group PLC (0.81%). Company insiders that own Baxter International stock include Albert P L Stroucken, Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Institutional Ownership Trends for Baxter International.

BAX stock was sold by a variety of institutional investors in the last quarter, including Veritas Asset Management LLP, BlackRock Inc., Wells Fargo & Company MN, Point72 Asset Management L.P., Mitsubishi UFJ Trust & Banking Corp, TIAA CREF Investment Management LLC, The Manufacturers Life Insurance Company and Acadian Asset Management LLC. Company insiders that have sold Baxter International company stock in the last year include Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, Peter S Hellman and Scott Pleau. View Insider Buying and Selling for Baxter International.

BAX stock was purchased by a variety of institutional investors in the last quarter, including Standard Life Aberdeen plc, Schroder Investment Management Group, FMR LLC, Prudential Financial Inc., Thrivent Financial for Lutherans, Man Group plc, Janus Henderson Group PLC and Stevens Capital Management LP. View Insider Buying and Selling for Baxter International.

Shares of BAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of BAX stock can currently be purchased for approximately $64.41.

Baxter International has a market capitalization of $35.39 billion and generates $10.56 billion in revenue each year. The medical instruments supplier earns $717 million in net income (profit) each year or $2.48 on an earnings per share basis. Baxter International employs 47,000 workers across the globe.

The official website for Baxter International is http://www.baxter.com.

Baxter International's mailing address is One Baxter Parkway, DEERFIELD IL, 60015. The medical instruments supplier can be reached via phone at 224-948-2000 or via email at [email protected]